Bankole A. Johnson
Department of Psychiatry
University of Texas Health Science Center
7703 Floyd Curl Dr
Mail Stop 7792
USA
Name/email consistency: high
- Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wallace, C., Wells, L.T., Wang, Y. Psychopharmacology (Berl.) (2005)
- Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics. Johnson, B.A., Swift, R.M., Ait-Daoud, N., DiClemente, C.C., Javors, M.A., Malcolm, R.J. Alcohol. Clin. Exp. Res. (2004)
- Effects of isradipine on cocaine-induced subjective mood. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Wells, L.T., Mauldin, J.B. J. Clin. Psychopharmacol (2004)
- Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Johnson, B.A. Alcohol. Clin. Exp. Res. (2004)
- An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Johnson, B.A. Expert. Opin. Pharmacother (2004)
- Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?. Johnson, B.A. Addict. Behav (2004)
- Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Johnson, B.A., Ait-Daoud, N., Akhtar, F.Z., Ma, J.Z. Arch. Gen. Psychiatry (2004)
- A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence. Johnson, B.A., Ait-Daoud, N., Aubin, H.J., Van Den Brink, W., Guzzetta, R., Loewy, J., Silverman, B., Ehrich, E. Alcohol. Clin. Exp. Res. (2004)
- Uses of topiramate in the treatment of alcohol dependence. Johnson, B.A. Expert. Rev. Neurother (2004)
- Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Johnson, B.A., Ait-Daoud, N., Bowden, C.L., DiClemente, C.C., Roache, J.D., Lawson, K., Javors, M.A., Ma, J.Z. Lancet (2003)
- Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Johnson, B.A., O'Malley, S.S., Ciraulo, D.A., Roache, J.D., Chambers, R.A., Sarid-Segal, O., Couper, D. J. Clin. Psychopharmacol (2003)
- The role of serotonergic agents as treatments for alcoholism. Johnson, B.A. Drugs. Today (2003)
- Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Johnson, B.A., Ait-Daoud, N., Ma, J.Z., Wang, Y. Alcohol. Clin. Exp. Res. (2003)
- Ondansetron reduces the craving of biologically predisposed alcoholics. Johnson, B.A., Roache, J.D., Ait-Daoud, N., Zanca, N.A., Velazquez, M. Psychopharmacology (Berl.) (2002)
- Treatment advances for cocaine-induced ischemic stroke: focus on dihydropyridine-class calcium channel antagonists. Johnson, B.A., Devous, M.D., Ruiz, P., Ait-Daoud, N. Am. J. Psychiatry (2001)
- Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. Johnson, B.A., Ait-Daoud, N., Prihoda, T.J. Alcohol. Clin. Exp. Res. (2000)
- Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Johnson, B.A., Ait-Daoud, N. Psychopharmacology (Berl.) (2000)
- Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. Johnson, B.A., Roache, J.D., Javors, M.A., DiClemente, C.C., Cloninger, C.R., Prihoda, T.J., Bordnick, P.S., Ait-Daoud, N., Hensler, J. JAMA (2000)
- Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis. Johnson, B.A. Alcohol. Clin. Exp. Res. (2000)
- Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Johnson, B.A., Roache, J.D., Bordnick, P.S., Ait-Daoud, N. Psychopharmacology (Berl.) (1999)
- Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced reduction in hunger. Johnson, B.A., Ait-Daoud, N., Bordnick, P.S. Prog. Neuropsychopharmacol. Biol. Psychiatry (1999)